Journal
ACTA BIOCHIMICA ET BIOPHYSICA SINICA
Volume 55, Issue 2, Pages 274-284Publisher
SCIENCE PRESS
DOI: 10.3724/abbs.2022122
Keywords
fibroblast; hypertrophic scar; lncRNA FPASL; MAPK; PI3K/AKT
Categories
Ask authors/readers for more resources
This study identifies a downregulated lncRNA called FPASL in hypertrophic scars and finds that its knockdown promotes fibroblast proliferation, while its overexpression inhibits fibroblast proliferation. Furthermore, the target genes of differentially expressed lncRNAs in hypertrophic scars are enriched in fibroblast proliferation signaling pathways. These findings contribute to a better understanding of the role of lncRNAs in hypertrophic scars and suggest that FPASL may act as a potential therapeutic target.
Hypertrophic scar is a problem for numerous patients, especially after burns, and is characterized by increased fibroblast proliferation and collagen deposition. Increasing evidence demonstrates that lncRNAs contribute to the development and progression of various diseases. However, the function of lncRNAs in hypertrophic scar formation remains poorly characterized. In this study, a novel fibroblast proliferation-associated lncRNA, named lncRNA FPASL (MSTRG.389905.1), which is mainly localized in the cytoplasm, is found to be downregulated in hypertrophic scar, as detected by lncRNA microarray and qRT-PCR. The full-length FPASL is characterized and further investigation confirms that it has no protein-coding potential. FPASL knockdown in fibroblasts triggers fibroblast proliferation, whereas overexpression of FPASL directly attenuates the proliferation of fibroblasts. Furthermore, target genes of the differentially expressed lncRNAs in hypertrophic scars and the matched adjacent normal tissues are enriched in fibroblast proliferation signaling pathways, including the PI3K/AKT and MAPK signaling pathways, as determined by GO annotation and KEGG enrichment analysis. We also demonstrate that knockdown of FPASL activates the PI3K/AKT and MAPK signaling pathways, and specific inhibitors of the PI3K/AKT and MAPK signaling pathways can reverse the proliferation of fibroblasts promoted by FPASL knockdown. Our findings contribute to a better understanding of the role of lncRNAs in hypertrophic scar and suggest that FPASL may act as a potential novel therapeutic target for hypertrophic scar.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available